MICROPUMP

Flamel Technologies, S.A.

Application Filed: 2006-01-15
Trademark Application Details
Trademark Logo MICROPUMP
602
Dead/Abandoned
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Research OneLook Acronym Finder
Serial Number78792034
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Domestic RepresentativeLisa A. Dunner
Attorney NameLisa A. Dunner
Attorney Docket NumberFLAM-018
Law Office AssignedM60
Employee NameCOWARD, KATHRYN E

Timeline

2006-01-15Application Filed
2006-11-20Abandon
2006-12-22Location: TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED
2006-12-22Status: Dead/Abandoned
2018-07-08Transaction Date

Trademark Applicants & Owners

Owner: Flamel Technologies, S.A.
Address33, Avenue du Dr. Georges Levy 69693 Venissieux C FR
Legal Entity TypeCorporation
Legal Entity State FR

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

LISA A. DUNNER
DUNNER LAW
WATERFRONT CENTER, SUITE 660
1010 WISCONSIN AVE., N.W.
WASHINGTON, DC 20007

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:42
U.S. Codes:100,101
Type CodeType
GS0051capsules for the oral administration of one or more medicinal and/or nutritional active principles (AP) and each providing a sustained and a controlled release of the AP in the small intestine, where the active principle can be antiulcer, antidiabetic, anticoagulant, antithrombic, hypolipaemic, antiarrhythmic, vasodilatory, antianginal, antihypertensive, and vasoprotective agents, fertility enhancers, labor inducers and inhibitors, and contraceptive, antibiotic, antifungal, antiviral, anticancer, anti-inflammatory, analgesic, antiepileptic, antiparkinsonian, neuroleptic, hypnotic, anxiolytic, psychostimulatory, antimigraine, antidepressant, antitussive, antihistamine or anti-allergic agents, such as but not limited to acetylsalicylic acid, pentoxifyllin, prazosin, acyclovir, nifedipin, diltiazem, naproxen, ibuprofen, flurbiprofen, ketoprofen, fenoprofen, indomethacin, diclofenac, fenitazac, oestradiol valerate, metoprolol, sulpiride, captopril, cimetidin, zidovudin, nicardipin, terfanadin, atenolol, salbutamol, carbamazepin, ranitidin, enalapril, simvastatin, fluoxetin, alprazolam, famotidin, ganciclovir, famiciclovir, spironolacton, 5-ASA, quinidin, perindopril, morphin, pentazocin, paracetamol, omeprazol, metoclopramid and mixtures thereof, and where the active principle can also be medicinal-nutritional and/or dietary supplements of mixtures thereof, such as but not limited to vitamins, amino acids, antioxidants, trace elements or mixtures thereof; Medicinal and pharmaceutical preparations in the form of capsules having controlled release active principles

Trademark Filing History

DescriptionDateEvent Coding
NEW APPLICATION ENTERED IN TRAM2006-01-191 NWAP I:Incoming Correspondence
ASSIGNED TO EXAMINER2006-05-182 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN2006-05-193 CNRT R:Renewal
NON-FINAL ACTION E-MAILED2006-05-194 GNRT F:First Action
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE2006-12-225 ABN2 O:Outgoing Correspondence
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND2006-12-266 MAB2 O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed